Alibaba Health Information Technology Ltd (0241)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 2.845 |
|---|---|
| 52-week range | 2.745 – 7.910 |
| Return, 1 month / 3 months | +0.0% / −14.7% |
| Return, 1 year / 3 years | −51.7% / −35.6% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -63.2% |
| Average daily value traded | 232.20M HKD |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alibaba Health Information Technology runs an online healthcare and pharmaceutical platform in China. Through its apps and websites, it sells medicines, health products and medical devices to consumers, and it connects patients with doctors for online consultations and prescription services. The company also offers services to pharmacies, hospitals and other healthcare providers, helping them reach customers digitally. It is based in China and is part of the Alibaba Group.
Alibaba Health Information Technology Ltd trades under the code 0241 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alibaba Health Information Technology Ltd (0241) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 2.845 on 22 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 1,865 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 51.7% and over the last three months it fell 14.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -31.8% | ||
| From 52-week high | -63.4% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.7% | ||
| 6-month return | -37.0% | ||
| 12-month return, skipping the last month | -51.7% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -63.2% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 232.20M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 11 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | +0.0% |
| 3 months | −14.7% |
| 6 months | −37.0% |
| 1 year | −51.7% |
| 3 years | −35.6% |
| 5 years | −77.0% |
Signals
| 50-day / 200-day average | 3.015 / 4.170 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.090 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Aug 2026 | HKD 0.0687 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.